Tolerization of anti-Galalpha1-3Gal natural antibody-forming B cells by induction of mixed chimerism. - Wikidata - wikimedia - TriplyDB

Tolerization of anti-Galalpha1-3Gal natural antibody-forming B cells by induction of mixed chimerism.

Tolerization of anti-Galalpha1-3Gal natural antibody-forming B cells by induction of mixed chimerism.

http://www.wikidata.org/entity/Q36400683

about

Transplantation tolerance and its outcome during infections and inflammation Desensitization for solid organ and hematopoietic stem cell transplantation Clinical xenotransplantation of organs: why aren't we there yet?Gut microbiota elicits a protective immune response against malaria transmission Tolerization of Gal alpha 1,3Gal-reactive B cells in pre-sensitized alpha 1,3-galactosyltransferase-deficient mice by nonmyeloablative induction of mixed chimerism.Expression of xenogeneic MHC class II molecules in HLA-DR(+) and -DR(-) cells: influence of retrovirus vector design and cellular context.Efficacy and limitations of cyclophosphamide-induced tolerance against alphaGal antigen.Sequential analysis of anti-alpha Gal natural antibody-producing B cells in GalT knockout mice in cyclophosphamide-induced tolerance.Impact of Mixed Xenogeneic Porcine Hematopoietic Chimerism on Human NK Cell Recognition in a Humanized Mouse Model Tolerance by transplantation: how much is enough, how much is too much?Prospects for xenotransplantation.Parasite Carbohydrate Vaccines.Current status of xenotransplantation.Mixed chimerism induced without lethal conditioning prevents T cell- and anti-Gal alpha 1,3Gal-mediated graft rejection Farming for spare body parts: silk purse or sow's ear.Conserved natural IgM antibodies mediate innate and adaptive immunity against the opportunistic fungus Pneumocystis murina.Donor bone marrow-derived T cells inhibit GVHD induced by donor lymphocyte infusion in established mixed allogeneic hematopoietic chimeras.Recent strategies to overcome the hyperacute rejection in pig to human xenotransplantation.The immunological hurdles to cardiac xenotransplantation.Clinical xenotransplantation: pigs might fly?B cell tolerance to xenoantigens.High incidence of xenogenic bone marrow engraftment in pig-to-baboon intra-bone bone marrow transplantation B-cell extrinsic CR1/CR2 promotes natural antibody production and tolerance induction of anti-alphaGAL-producing B-1 cells Development and tolerization of hyperacute rejection in a transgenic mouse graft versus host model.Organ transplantation--how much of the promise has been realized?The immunobiology of Guillain-Barré syndromes.Immune tolerance: mechanisms and application in clinical transplantation.High antigen levels do not preclude B-cell tolerance induction to alpha1,3-Gal via mixed chimerism.B cell clonal elimination induced by membrane-bound self-antigen may require repeated antigen encounter or cell competition Manipulating the immune system for anti-tumor responses and transplant tolerance via mixed hematopoietic chimerism.Induction of human T-cell tolerance to pig xenoantigens via thymus transplantation in mice with an established human immune system.Hematopoietic cell transplantation for tolerance induction: animal models to clinical trials Rat-to-Chinese tree shrew heart transplantation is a novel small animal model to study non-Gal-mediated discordant xenograft humoral rejection.Immunological challenges and therapies in xenotransplantation.CD47 in xenograft rejection and tolerance induction.Experimental models of B cell tolerance in transplantation.Xenotransplantation: immunological hurdles and progress toward tolerance.Carbohydrate residues downstream of the terminal Galalpha(1,3)Gal epitope modulate the specificity of xenoreactive antibodies.B-cell tolerance in transplantation: is repertoire remodeling the answer?Xenogeneic lung transplantation models.

P2860

Q26829817-CC4AC9CC-BA0B-4732-94C9-6F4AD456ADEA Q26863564-5BC476C8-2458-4F9D-A0A6-8348B1E97408 Q28221527-565F55E2-FC13-4DF5-A761-B170E4F4FB84 Q28253398-AE671713-760E-491B-86C5-B42769B33033 Q30775438-B959C0F9-9C78-41C1-8859-B4939FAB3947 Q31042661-845FBF63-E303-40C5-B511-123FB226947B Q33223831-648E6C51-6B76-4E94-9440-D02E59721C20 Q33246284-1D35FDE5-0D47-4D64-AC49-1F3815980DA8 Q33629253-02CA0AB9-F094-4EF8-AD39-43C28FFCD148 Q33701846-24C22AE9-0E6B-46DE-9AEE-4466AED359E5 Q33732951-6065C2A8-6F45-4494-B2D1-896911DEC8A4 Q33785863-255CBECA-D60C-408F-ABA1-D9C15F2A7B45 Q33811452-CD215395-74D4-4755-AB21-6C0C45811E03 Q33853565-2AD5AE06-5ABC-49ED-BDDA-65DBFF646042 Q34286605-0CB03CD1-5B4B-4028-8E8C-11A7E9CAD606 Q34420814-0102500E-BA3A-4151-BD6F-184DE8FD9795 Q34450566-CEC82FEC-68A8-4113-A18D-04E3D4327758 Q34479577-600BB78D-64CD-4BFB-94A1-3690075B3EE5 Q34582619-CDAC75CE-61D3-4179-8F05-B3F69A3FDC95 Q34874199-F0325B8F-9BEC-431D-9355-BF46477FF2CB Q35067199-FF1AFD8E-FAFE-466B-96EE-7E8869B66134 Q35532677-2609D0CA-0583-4C2B-9909-543C25B061E2 Q35628964-C5C40EC3-D6CF-4EB0-88CC-8D41318511FD Q36149897-04465D1E-434A-436F-871B-748701C597F8 Q36152685-7A703578-DCDB-4955-A5E9-32C05E7633A5 Q36164122-8BE82075-EF60-49DC-8DFD-5109C3F3DE4B Q36909564-088F790A-CB65-443C-8778-AAE72070D0A1 Q37077908-C2176F12-53C3-4971-A8F1-49044FA1C276 Q37183454-F6E1F6FE-AB31-43F6-851A-043D80C6B2F3 Q37211290-543462E0-1A15-4929-BAEE-C254B0C8237A Q37363576-38D449A1-F756-4A98-A595-B9DCC9AFF832 Q37388414-4C12A39D-BE31-44D0-AF7E-2027441F7C19 Q37600806-BC49956A-147E-4020-94AA-1C0C6071BC26 Q37670770-30CC5497-F883-4388-81F2-A3B649D92F3E Q37781118-E826C5AC-92A8-4524-9492-2986F2CA85DF Q37934146-D3EC54DA-356C-4DE7-A9C2-C1509A7716A0 Q38187179-0D8BAD2B-A0BC-42CA-9AF3-74DD394C4459 Q38298848-A5236808-C145-43B5-9BF2-464970B9CC45 Q42038591-A2329B28-4740-4AD4-B0E1-9577E957E341 Q42247993-845466AD-77F8-445D-8112-4428325D6AA1

P2860

Tolerization of anti-Galalpha1-3Gal natural antibody-forming B cells by induction of mixed chimerism.

http://www.wikidata.org/entity/Q36400683

description

1998 nî lūn-bûn

@nan

1998年の論文

@ja

1998年学术文章

@wuu

1998年学术文章

@zh-cn

1998年学术文章

@zh-hans

1998年学术文章

@zh-my

1998年学术文章

@zh-sg

1998年學術文章

@yue

1998年學術文章

@zh

1998年學術文章

@zh-hant

name

Tolerization of anti-Galalpha1 ...... induction of mixed chimerism.

@ast

Tolerization of anti-Galalpha1 ...... induction of mixed chimerism.

@en

type

label

Tolerization of anti-Galalpha1 ...... induction of mixed chimerism.

@ast

Tolerization of anti-Galalpha1 ...... induction of mixed chimerism.

@en

prefLabel

Tolerization of anti-Galalpha1 ...... induction of mixed chimerism.

@ast

Tolerization of anti-Galalpha1 ...... induction of mixed chimerism.

@en

P1433

Q36400683-D3C5C2AE-EE18-4125-95F1-E947A4CFFDC9

P1476

Q36400683-46B860F4-B027-4AD4-BA4A-735C087A437C

P2093

Q36400683-19CB54C5-B820-49B2-839E-4DB5935E45A7

Q36400683-26C6B034-EF99-40E4-96E0-13DE53AC047A

Q36400683-78CE40A2-A799-475F-8E18-E79256155938

Q36400683-AB38F60F-0836-4D64-ADF8-78716353FB26

Q36400683-E3596B7F-384C-494B-8DB1-D115C71AA3A5

Q36400683-EAF6D281-DCAD-49BD-9B17-04EB1B17F8FC

Q36400683-F5DA4F91-701B-4F42-BCF3-42689775120F

Q36400683-FCA5484C-3910-4B63-8035-D2A4EABDBDBB

P2860

Q36400683-0FA6D2A7-A3E8-4D92-99EF-E66309AFBB40

Q36400683-116687CE-68F8-4857-A927-300EE0B7C25C

Q36400683-12015963-C08E-406B-9AAC-AA47039C231C

Q36400683-17514616-C270-4E02-95B0-B17CED326FA6

Q36400683-1C6CAEB6-1D42-4299-836C-6650FC253D47

Q36400683-1D6542DA-8C9B-4D64-982F-40595C87CF30

Q36400683-2F775DCC-D6AA-4198-BC90-8892648748B0

Q36400683-30DC3FDA-9CF4-48F3-B853-D67550F719AF

Q36400683-4B99E03A-9173-4BC9-B2B0-CFBB4A942C9E

Q36400683-4CFC9D14-74DE-4553-917B-2759D3FD70FA

P304

Q36400683-4AC67F6A-196A-4CE1-A6D1-53F5C26ACEAA

P31

Q36400683-380E0C7E-C0BB-4C9E-8A3C-906AA342E22E

P356

Q36400683-A053BBE5-49BA-496B-A708-AF2778156B4F

P407

Q36400683-09198866-1ECA-4BF4-A45F-D8D649C73D7F

P433

Q36400683-70412869-422C-4DF0-B14C-AABE24919ABE

P478

Q36400683-5461C815-5EEF-4DAF-B6E8-4DDA5FBEF4B9

P577

Q36400683-BB8AA0B4-4D7C-4C3E-9A2C-AF8A27D6F2AF

P5875

Q36400683-D5E9B4B7-0A04-4120-A993-4435E9DCC3DA

P698

Q36400683-844D15CF-4FB6-4F03-B480-6779546C6AC8

P921

Q36400683-F657BFF7-3E29-4908-AF4E-73DF71DB2235

P932

Q36400683-68F89E37-BEFA-4299-96E2-A0EFC20D208F

P356

P1433

Journal of Experimental Medicine

P1476

Tolerization of anti-Galalpha1 ...... induction of mixed chimerism.

@en

P2093

A D Thall

http://www.w3.org/2001/XMLSchema#string

E deGoma

http://www.w3.org/2001/XMLSchema#string

H Ohdan

http://www.w3.org/2001/XMLSchema#string

J Iacomini

http://www.w3.org/2001/XMLSchema#string

J L Bracy

http://www.w3.org/2001/XMLSchema#string

M Sykes

http://www.w3.org/2001/XMLSchema#string

Y G Yang

http://www.w3.org/2001/XMLSchema#string

Y Xu

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes

Specific tolerance induction across a xenogeneic barrier: production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen.

Clonal deletion of autoreactive B lymphocytes in bone marrow chimeras

Reduction in the level of Gal(alpha1,3)Gal in transgenic mice and pigs by the expression of an alpha(1,2)fucosyltransferase

A transgenic model of autoimmune hemolytic anemia.

Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors

Self recognition in allogeneic radiation bone marrow chimeras. A radiation-resistant host element dictates the self specificity and immune response gene phenotype of T-helper cells.

Long-lasting skin allograft tolerance in adult mice induced across fully allogeneic (multimajor H-2 plus multiminor histocompatibility) antigen barriers by a tolerance-inducing method using cyclophosphamide.

Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen.

Receptor editing in self-reactive bone marrow B cells.

P304

1335-1342

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.187.8.1335

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

187

http://www.w3.org/2001/XMLSchema#string

P577

1998-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13725900

http://www.w3.org/2001/XMLSchema#string

P698

9547344

http://www.w3.org/2001/XMLSchema#string

P921

P932

2212239

http://www.w3.org/2001/XMLSchema#string